护理学报 ›› 2019, Vol. 26 ›› Issue (21): 26-30.doi: 10.16460/j.issn1008-9969.2019.21.026
隆莉芝, 袁玲, 严婷婷, 方丽
摘要: 目的 综述患者报告结局在头颈癌的应用进展,为相关的临床研究和护理实践提供参考。方法 复习近年头颈癌患者报告结局的国内外相关文献,从工具介绍、应用进展进行分析和归纳。结果 头颈癌患者报告结局的工具包括通用工具和特异性工具,即欧洲癌症研究与治疗组织生命质量核心量表,欧洲癌症研究与治疗组织生命质量量表-头颈部模块,埃德蒙顿症状评估系统,安德森症状量表-头颈部模块,安德森吞咽困难量表等。头颈癌患者报告结局的应用包括症状监测、营养评估、临床试验中的应用。结论 患者报告结局可用于监测治疗进展,评估疾病的复发,并给予个性化的治疗方案。然而把患者报告结局应用于实践中仍存在一些障碍,需要时间和资源的投入,患者报告结局测量工具有待研发,移动互联网的普及提出了新挑战等,有待未来深入研究。
中图分类号:
[1] Yuan A, Sonis S.Emerging Therapies for the Prevention and Treatment of Oral Mucositis[J]. Expert Opin Emerg Drugs, 2014, 19(3):343-351.DOI:10.1517/14728214.2014.946403. [2] Kyte D G, Calvert M, Van Der Wees P J, et al. An Introduction to Patient-reported Outcome Measures (Proms) in Physiotherapy[J]. Physiotherapy, 2015, 101(2):119-125. DOI:10.1016/J.Physio.2014.11.003. [3] Bingham C O, Noonan V K, Auger C, et al.Montreal Accord on Patient-reported Outcomes (Pros) Use Series-paper 4: Patient-reported Outcomes Can Inform Clinical Decision Making in Chronic Care[J]. J Clin Epidemiol, 2017, 89:136-141. DOI:10.1016/J.Jclinepi.2017.04.014. [4] Evaluation T, Evaluation A, Devices A, et al. Guidance for Industry Patient-reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims[EB/OL]. [2018-08-22].Http://www.Fda.Gov/Drugs/Guidancecomplianceregulatory information/Guidances/Default.Htm. [5] Department of Health(2009). Guidance on the Routine Collection of Patient Reported Outcome Measures(PROMs)[EB/OL].(2008-12-08)[2018-07-14].http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_092625.pdf [6] 李娜. 比较电子化和传统纸质病人报告结局在神经科学临床研究中的应用[D]. 上海: 复旦大学, 2012. [7] Coons S J, Gwaltney C J, Hays R D, et al.Recommendations on Evidence Needed to Support Measurement Equivalence Between Electronic and Paper-based Patient-reported Outcome (PRO) Measures: ISPOR Epro Good Research Practices Task Force Report[J].Value Health, 2009, 12(4):419-429. DOI:10.1111/J.1524-4733.2008.00470.X. [8] Muehlhausen W, Doll H, Quadri N, et al.Equivalence of Electronic and Paper Administration of Patient-reported Outcome Measures: A Systematic Review and Meta-analysis of Studies Conducted between 2007 and 2013[J]. Health Qual Life Outcomes, 2015, 13:167. DOI:10.1186/S12955-015-0362-X. [9] Dueck A C, Mendoza T R, Mitchell S A, et al.Validity and Reliability of the US National Cancer Institute’s Patient-reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)[J]. JAMA Oncol,2015, 1(8):1051-1059.DOI:10.1001/jamaoncol.2015.2639. [10] Gunn G B,Atalar B,Mendoza T R,et al.Linguistic Validation of the Turkish Version of the M.D.Anderson Symptom Inventory-head and Neck Cancer Module[J].Balkan Med J, 2016,33(3):339-343.DOI:10.5152/Balkanmedj.2015.150148. [11] Zeng L, Koo K, Zhang L, et al.Fatigue in Advanced Cancer Patients Attending an Outpatient Palliative Radiotherapy Clinic as Screened by the Edmonton Symptom Assessment System[J]. Support Care Cancer, 2012, 20(5):1037-1042. DOI:10.1007/S00520-011-1179-8. [12] Watanabe S M, Nekolaichuk C L, Beaumont C.The Edmonton Symptom Assessment System, A Proposed Tool for Distress Screening in Cancer Patients: Development and Refinement[J]. Psychooncology, 2012, 21(9):977-985. DOI:10.1002/Pon.1996. [13] Dong Y, Chen H, Zheng Y, et al. Psychometric Validation of the Edmonton Symptom Assessment System in Chinese Patients[J]. J Pain Symptom Manage, 2015, 50(5):712-717.e2. DOI:10.1016/J.Jpainsymman.2015.05.018. [14] National Institutes of Health. Patient-reported Outcomes Measurement Information System - annoucements[EB/OL].[2019-04-30]. https://Commonfund.Nih.Gov/Promis/Index. [15] Ringash J, Bernstein L J, Cella D, et al.Outcomes Toolbox for Head and Neck Cancer Research[J]. Head Neck, 2015, 37(3):425-439. DOI:10.1002/Hed.23561. [16] Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al.Development of a European Organization for Research and Treatment of Cancer (EORTC) Questionnaire Module to Be Used in Quality of Life Assessments in Head and Neck Cancer Patients. EORTC Quality of Life Study Group[J]. Acta Oncol,1994,33(8):879-885.DOI:10.3109/0284186940098450. [17] 肖巍魏,韩非,赵充,等. 鼻咽癌患者生存质量FACT-H&N量表测评[J]. 中国公共卫生, 2010, 26(7):827-829. DOI:10.11847/Zgggws2010-26-07-13. [18] Wyatt G, Pugh S L, Wong R K, et al.Xerostomia Health-Related Quality of Life: NRG Oncology RTOG 0537[J]. Qual Life Res,2016, 25(9):2323-2333.DOI:10.1007/S11136-016-1255-0. [19] Gunn G B, Mendoza T R, Fuller C D, et al.High Symptom Burden Prior to Radiation Therapy for Head and Neck Cancer: A Patient-reported Outcomes Study[J]. Head Neck, 2013, 35(10):1490-1498. DOI:10.1002/Hed.23181. [20] Chen A Y, Frankowski R, Bishop-Leone J, et al.The Development and Validation of a Dysphagia-specific Quality-of-life Questionnaire for Patients with Head and Neck Cancer:The M.D.Anderson Dysphagia Inventory[J]. Arch Otolaryngol Head Neck Surg, 2001,127(7):870-876. [21] 邹敏,席淑新,吴沛霞,等. 中文版安德森吞咽困难量表的信效度研究[J]. 中华护理杂志, 2013, 48(11):1003-1007.DOI:10.3761/J.Issn.0254-1769.2013.11.013. [22] Zhang L J, Jiang N, Li Z, et al.Psychometric Properties of the Chinese Version of the M.D.Anderson Dysphagia Inventory for Head and Neck Cancer Patients[J]. Cancer Nurs,2017,40(3):E9-E16.DOI:10.1097/NCC.0000000000000397. [23] Hollander-Mieritz C, Johansen J, Johansen C, et al.Comparing the Patients’ Subjective Experiences of Acute Side Effects during Radiotherapy for Head and Neck Cancer with Four Different Patient-reported Outcomes Questionnaires[J]. Acta Oncol, 2019, 58(5):603-609. DOI:10.1080/0284186X.2018.1563713. [24] Hanna E Y, Mendoza T R, Rosenthal D I, et al.The Symptom Burden of Treatment-naive Patients with Head and Neck Cancer[J]. Cancer, 2015, 121(5):766-773. DOI:10.1002/Cncr.29097. [25] Chiang S H, Ho K Y, Wang S Y, et al.Change in Symptom Clusters in Head and Neck Cancer Patients Undergoing Postoperative Radiotherapy: A Longitudinal Study[J]. Eur J Oncol Nurs, 2018, 35:62-66. DOI:10.1016/J.Ejon.2018.01.014. [26] Belqaid K, Orrevall Y, Mcgreevy J, et al.Self-reported Taste and Smell Alterations in Patients Under Investigation for Lung Cancer[J]. Acta Oncol, 2014, 53(10):1405-1412. DOI:10.3109/0284186X.2014.895035. [27] Jin S, Lu Q, Jin S, et al.Relationship between Subjective Taste Alteration and Weight Loss in Head and Neck Cancer Patients Treated with Radiotherapy: A Longitudinal Study[J]. Eur J Oncol Nurs, 2018, 37:43-50. DOI:10.1016/J.Ejon.2018.10.003. [28] Sozeri E, Kutluturkan S.The Validity and Reliability of Turkish Version of the Chemotherapy-induced Taste Alteration Scale (Citas)[J]. Clin Nurs Res, 2018, 27(2):235-249. DOI:10.1177/1054773816662436. [29] Pang D, Qian L, Chen Z J, et al.Psychometric Properties of the Chinese Version of the Chemotherapy-induced Taste Alteration Scale[J]. Eur J Oncol Nurs, 2019,42:7-13. DOI:10.1016/J.Ejon.2019.07.007. [30] Wu Y S, Lin P Y, Chien C Y, et al.Anxiety and Depression in Patients with Head and Neck Cancer: 6-Month Follow-up Study[J]. Neuropsychiatr Dis Treat, 2016, 12:1029-1036. DOI:10.2147/NDT.S103203. [31] Rohde R L, Adjei Boakye E, Challapalli S D, et al.Prevalence and Sociodemographic Factors Associated with Depression among Hospitalized Patients with Head and Neck Cancer-results from a National Study[J]. Psychooncology, 2018, 27(12):2809-2814. DOI:10.1002/Pon.4893. [32] Martin L, De Van Der Schueren M A E, Blauwhoff-Buskermolen S, et al. Identifying the Barriers and Enablers to Nutrition Care in Head and Neck and Esophageal Cancers[J]. JPEN, 2016, 40(3):355-366.DOI:10.1177/0148607114552847. [33] Alberda C, Alvadj-Korenic T, Mayan M, et al.Nutrition Care in Patients with Head and Neck or Esophageal Cancer: The Patient Perspective[J]. Nutr Clin Pract,2017, 32(5):664-674.DOI:10.1177/0884533617725050. [34] Britton B, Clover K, Bateman L, et al.Baseline Depression Predicts Malnutrition in Head and Neck Cancer Patients Undergoing Radiotherapy[J]. Support Care Cancer, 2012, 20(2):335-342.DOI:10.1007/S00520-011-1087-Y. [35] Citak E, Tulek Z, Uzel O.Nutritional Status in Patients with Head and Neck Cancer Undergoing Radiotherapy: A Longitudinal Study[J]. Support Care Cancer, 2019, 27(1):239-247. DOI:10.1007/S00520-018-4319-6. [36] Kubrak C, Olson K, Baracos V E.The Head and Neck Symptom Checklist©:An Instrument to Evaluate Nutrition Impact Symptoms Effect on Energy Intake and Weight Loss[J]. Support Care Cancer, 2013, 21(11):3127-3136. DOI:10.1007/S00520-013-1870-Z. [37] Jin S, Lu Q, Pang D, et al.Validation of the Chinese Version of the Head and Neck Patient Symptom Checklist for Measuring Nutrition Impact Symptoms during Radiotherapy in Patients with Head and Neck Cancer[J]. Support Care Cancer, 2019, 27(12):4705-4711. DOI:10.1007/S00520-019-04784-3. [38] Stover A, Irwin D E, Chen R C, et al.Integrating Patient-Reported Outcome Measures into Routine Cancer Care: Cancer Patients’ and Clinicians’ Perceptions of Acceptability and Value[J]. EGEMS (Wash DC), 2015, 3(1): 1169. DOI:10.13063/2327-9214.1169. [39] Moon D H, Chera B S, Deal A M, et al.Clinician-observed and Patient-reported Toxicities and Their Association with Poor Tolerance to Therapy in Older Patients with Head and Neck or Lung Cancer Treated with Curative Radiotherapy[J]. J Geriatr Oncol, 2019,10(1):42-47.DOI:10.1016/J.Jgo.2018.05.016. [40] Atkinson T M, Ryan S J, Bennett A V, et al.The Association between Clinician-based Common Terminology Criteria for Adverse Events (CTCAE) and Patient-reported Outcomes (PRO): A Systematic Review[J]. Support Care Cancer, 2016, 24(8):3669-3676. DOI:10.1007/S00520-016-3297-9. [41] Basch E, Reeve B B, Mitchell S A, et al.Development of the National Cancer Institute’s Patient-reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)[J]. J Natl Cancer Inst, 2014, 106(9).DOI:10.1093/Jnci/Dju244. [42] Van Der Wees P J, Nijhuis-Van Der Sanden M W, Ayanian J Z, et al. Integrating the Use of Patient-reported Outcomes for both Clinical Practice and Performance Measurement: Views of Experts From 3 Countries[J]. Milbank Q, 2014, 92(4):754-775. DOI:10.1111/1468-0009.12091. [43] Bevans M, Ross A, Cella D.Patient-Reported Outcomes Measurement Information System (PROMIS): Efficient, Standardized Tools to Measure Self-reported Health and Quality of Life[J]. Nurs Outlook, 2014, 62(5):339-345. DOI:10.1016/j.outlook.2014.05.009. |
[1] | 黄媛媛, 傅巧美, 刘光香, 白雅馨, 张青. 肾移植患者基于“互联网+”延续护理的效果观察[J]. 护理学报, 2020, 27(8): 69-72. |
[2] | 李寅翠, 刘云, 李莹, 韩雪, 孟嘉. 术前睡眠质量对全膝关节表面置换患者术后早期康复及生活质量的影响[J]. 护理学报, 2020, 27(4): 42-47. |
[3] | 刘熠, 欧阳艳琼, 黄毅, 聂小菲. 正念减压疗法对乳腺癌患者干预效果的Meta分析[J]. 护理学报, 2019, 26(8): 31-36. |
[4] | 张鲁敏, 顾芬, 任皎皎, 陈刘莺. 叙事护理对COPD患者焦虑抑郁及生活质量的影响[J]. 护理学报, 2019, 26(7): 65-69. |
[5] | 杜红娣, 刘彩云, 刘晓萱, 王琳琳, 李莹, 霍晓鹏. 基于蒙台梭利教育理论干预对轻中度老年痴呆患者认知功能及生活质量的影响[J]. 护理学报, 2019, 26(5): 59-62. |
[6] | 朱冰洁, 李佳倩, 黄孟秋, 王蕊, 阎玲. 154例乳腺癌化疗患者症状管理自我效能影响因素分析[J]. 护理学报, 2019, 26(18): 42-46. |
[7] | 于歌, 崔金金. 二元应对模式对慢性心力衰竭患者生活质量及其配偶间亲密关系的影响[J]. 护理学报, 2019, 26(16): 63-67. |
[8] | 蔡晓艳, 邓小岚, 张智. 玩偶疗法对阿尔茨海默病患者认知功能和生活质量的影响[J]. 护理学报, 2019, 26(10): 73-76. |
[9] | 李燕, 单亚维, 张翠娣. 慢性肾脏病中晚期患者体力活动干预方案及评估工具研究进展[J]. 护理学报, 2019, 26(1): 40-44. |
[10] | 王玲,孙丹,郑莉. 肝移植受者术后小组活动健康教育的效果观察[J]. 护理学报, 2018, 25(6): 64-67. |
[11] | 黄孟秋,吴婷,张青月,王燕,庞微,阎玲. 症状管理自我效能在乳腺癌患者化疗期间焦虑抑郁与生活质量的中介作用[J]. 护理学报, 2018, 25(4): 65-69. |
[12] | 罗香莲, 黄雅莲, 方艳春, 宋春莲, 朱婷, 徐俊敏. 团体爱笑瑜伽对维持性血液透析患者生活质量的影响[J]. 护理学报, 2018, 25(22): 1-5. |
[13] | 吴静, 丁晓平, 耿在香. 住院康复期精神分裂症患者正念训练的效果观察[J]. 护理学报, 2018, 25(20): 64-67. |
[14] | 张琼,尹安春. 痴呆老人家庭照顾者生活质量及其影响因素研究进展[J]. 护理学报, 2018, 25(16): 22-26. |
[15] | 陈洁,薄海欣,段艳萍. 女性不孕症患者生育生活质量及影响因素研究[J]. 护理学报, 2018, 25(13): 1-5. |
|